AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Erodible Polymer Particle Oral Vaccine Adjuvant

Detailed Technology Description: Heliobacter pylori is a known cause of gastric cancer, and over half of the world’s population is infected with H. pylori. According to the World Health Organization, gastric cancer caused by H. pylori is the third leading cause of cancer mortality in the world. A novel nanoparticle adjuvant preparation has been developed which combines vaccination with an agent that enhances gastric inflammation, boosts immunity and improves clearance of the H. pylori. This novel strategy has been tested in vitro and in vivo (mouse studies).

Others: Intellectual Property Info
A provisional patent application has been filed.

Tech ID/UC Case
24979/2015-253-0

Related Cases
2015-253-0

*Abstract: None

*IP Issue Date: Nov 3, 2016

*Principal Investigator: Name: Peter Ernst
Department:

Name: Steven Josephs
Department:

Country/Region: USA

For more information, please click Here